Biofrontera AG

BFFTF · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$5,669-$257-$10,437$3,526
Dep. & Amort.-$13$309$307$295
Deferred Tax$0$0$0$6,096
Stock-Based Comp.$288$204$228$228
Change in WC-$2,960$342$2,618-$5,248
Other Non-Cash$7,146-$5,318$1,637-$13,763
Operating Cash Flow-$1,208-$4,720-$3,325-$8,866
Investing Activities
PP&E Inv.$0$48-$57$9
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$57$64
Other Inv. Act.$0-$50$57$64
Investing Cash Flow$0-$2$0$73
Financing Activities
Debt Repay.-$655$0-$357$0
Stock Issued-$7,438$7,438$7,662$4,507
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$357$5,284-$1,506$6,714
Financing Cash Flow-$298$5,284$5,799$6,714
Forex Effect$0$0$0$5,957
Net Chg. in Cash-$1,306$562$2,474-$2,079
Supplemental Information
Beg. Cash$4,379$3,817$1,343$3,422
End Cash$3,073$4,379$3,817$1,343
Free Cash Flow-$1,158-$4,722-$3,382-$8,857
Biofrontera AG (BFFTF) Financial Statements & Key Stats | AlphaPilot